Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin

American Journal of Roentgenology

Volumn 194, Issue 3, 2010, Pages 784-789

  Atwell, Thomas D ^a   Smith, Ryan L ^b   Hesley, Gina K ^a   Callstrom, Matthew R ^a   Schleck, Cathy D ^a   Harmsen, W Scott ^a   Charboneau, J William ^a   Welch, Timothy J ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Aspirin; Biopsy; Complications; Hemorrhage; Percutaneous biopsy

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; BLEEDING; BLOOD CLOTTING; HUMAN; IMAGING; INTERNATIONAL NORMALIZED RATIO; KIDNEY BIOPSY; LIVER BIOPSY; LUNG BIOPSY; PANCREAS BIOPSY; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ASPIRIN; BIOPSY; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77749298675     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.2122     Document Type: Article

References (36)

1. Giorgio A, Tarantino L, de Stefano G, et al. Complications after interventional sonography of focal liver lesions: a 22-year single-center experience. J Ultrasound Med 2003; 22:193-205
2. Feneberg R, Schaefer F, Zieger B, Waldherr R, Mehls O, Scharer K. Percutaneous renal biopsy in children: a 27-year experience. Nephron 1998; 79:438-446
3. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 99:1396-1400
4. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy: a multicentre retrospective study on 68,276 biopsies. J Hepatol 1986; 2:165-173
5. Parrish AE. Complications of percutaneous renal biopsy: a review of 37 years' experience. Clin Nephrol 1992; 38:135-141
6. Cancer Therapy Evaluation Program, National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). ctep.cancer. gov/protocolDevelopment/electronic-applications/ docs/ctcaev3.pdf. Published August 9, 2006. Accessed January 26, 2010
7. Livraghi T, Damascelli B, Lombardi C, Spagnoli I. Risk in fine-needle abdominal biopsy. J Clin Ultrasound 1983; 11:77-81
8. Fornari F, Civardi G, Cavanna L, et al. Complications of ultrasonically guided fine-needle abdominal biopsy: results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group. Scand J Gastroenterol 1989; 24:949-955
9. Van Thiel DH, Gavaler JS, Wright H, Tzakis A. Liver biopsy: its safety and complications as seen at a liver transplant center. Transplantation 1993; 55:1087-1090
10. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995; 36:437-441
11. Hergesell O, Felten H, Andrassy K, Kühn K, Ritz E. Safety of ultrasound-guided percutaneous renal biopsy: retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant 1998; 13:975-977
12. Firpi RJ, Soldevila-Pico C, Abdelmalek MF, Morelli G, Judah J, Nelson DR. Short recovery time after percutaneous liver biopsy: should we change our current practices? Clin Gastroenterol Hepatol 2005; 3:926-929
13. van der Poorten D, Kwok A, Lam T, et al. Twentyyear audit of percutaneous liver biopsy in a major Australian teaching hospital. Intern Med J 2006; 36:692-699
14. Shidham GB, Siddiqi N, Beres JA, et al. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology (Carlton) 2005; 10:305-310
15. Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 2004; 15:142-147
16. Meola M, Barsotti G, Cupisti A, Buoncristiani E, Giovannetti S. Free-hand ultrasound-guided renal biopsy: report of 650 consecutive cases. Nephron 1994; 67:425-430
17. Little AF, Ferris JV, Dodd GD 3rd, Baron RL. Image-guided percutaneous hepatic biopsy: effect of ascites on the complication rate. Radiology 1996; 199:79-83
18. Luning M, Schroder K, Wolff H, Kranz D, Hoppe E. Percutaneous biopsy of the liver. Cardiovasc Intervent Radiol 1991; 14:40-42
19. Terjung B, Lemnitzer I, Dumoulin FL, et al. Bleeding complications after percutaneous liver biopsy: an analysis of risk factors. Digestion 2003; 67:138-145
20. Wilczek HE. Percutaneous needle biopsy of the renal allograft: a clinical safety evaluation of 1129 biopsies. Transplantation 1990; 50:790-797
21. Mendelssohn DC, Cole EH. Outcomes of percutaneous kidney biopsy, including those of solitary native kidneys. Am J Kidney Dis 1995; 26:580-585
22. Preda A, Van Dijk LC, Van Oostaijen JA, Pattynama PM. Complication rate and diagnostic yield of 515 consecutive ultrasound-guided biopsies of renal allografts and native kidneys using a 14-gauge Biopty gun. Eur Radiol 2003; 13:527-530
23. Yeow KM, Su IH, Pan KT, et al. Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest 2004; 126:748-754
24. Tomiyama N, Yasuhara Y, Nakajima Y, et al. CTguided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan. Eur J Radiol 2006; 59:60-64
25. Zech CJ, Helmberger T, Wichmann MW, Holzknecht N, Diebold J, Reiser MF. Large core biopsy of the pancreas under CT fluoroscopy control: results and complications. J Comput Assist Tomogr 2002; 26:743-749
26. Mueller PR, Miketic LM, Simeone JF, et al. Severe acute pancreatitis after percutaneous biopsy of the pancreas. AJR 1988; 151:493-494
27. Paulsen SD, Nghiem HV, Negussie E, Higgins EJ, Caoili EM, Francis IR. Evaluation of imagingguided core biopsy of pancreatic masses. AJR 2006; 187:769-772
28. Brandt KR, Charboneau JW, Stephens DH, Welch TJ, Goellner JR. CT- and US-guided biopsy of the pancreas. Radiology 1993; 187:99-104
29. Atwell TD, Gorman B, Larson TS, Charboneau JW, Ingalls Hanson BM, Stegall MD. Pancreas transplants: experience with 232 percutaneous US-guided biopsy procedures in 88 patients. Radiology 2004; 231:845-849
30. Jacobs WH, Goldberg SB. Statement on outpatient percutaneous liver biopsy. Dig Dis Sci 1989; 34:322-323
31. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 2005; 257:399-414
32. Albaladejo P, Geeraerts T, Francis F, Castier Y, Leseche G, Marty J. Aspirin withdrawal and acute lower limb ischemia. Anesth Analg 2004; 99:440-443
33. Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45:456-459
34. Bachman DS. Discontinuing chronic aspirin therapy: another risk factor for stroke? Ann Neurol 2002; 51:137-138
35. Schafer AI. Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med 1999; 106:25S-36S
36. Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Radiology 1991; 178: 253-258